Home Cart 0 Sign in  
X

[ CAS No. 28721-09-7 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 28721-09-7
Chemical Structure| 28721-09-7
Chemical Structure| 28721-09-7
Structure of 28721-09-7 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 28721-09-7 ]

Related Doc. of [ 28721-09-7 ]

Alternatived Products of [ 28721-09-7 ]

Product Details of [ 28721-09-7 ]

CAS No. :28721-09-7 MDL No. :MFCD08460125
Formula : C16H14N2O2 Boiling Point : -
Linear Structure Formula :- InChI Key :PIZOFBKQWNPKDK-UHFFFAOYSA-N
M.W : 266.29 Pubchem ID :120031
Synonyms :

Calculated chemistry of [ 28721-09-7 ]

Physicochemical Properties

Num. heavy atoms : 20
Num. arom. heavy atoms : 12
Fraction Csp3 : 0.06
Num. rotatable bonds : 2
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 81.94
TPSA : 55.56 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : Yes
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : Yes
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.18 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.36
Log Po/w (XLOGP3) : 2.45
Log Po/w (WLOGP) : 2.87
Log Po/w (MLOGP) : 2.39
Log Po/w (SILICOS-IT) : 1.65
Consensus Log Po/w : 2.34

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.35
Solubility : 0.12 mg/ml ; 0.00045 mol/l
Class : Soluble
Log S (Ali) : -3.26
Solubility : 0.146 mg/ml ; 0.000549 mol/l
Class : Soluble
Log S (SILICOS-IT) : -4.27
Solubility : 0.0142 mg/ml ; 0.0000535 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 0.0
Synthetic accessibility : 3.1

Safety of [ 28721-09-7 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 28721-09-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 28721-09-7 ]
  • Downstream synthetic route of [ 28721-09-7 ]

[ 28721-09-7 ] Synthesis Path-Upstream   1~12

  • 1
  • [ 4698-11-7 ]
  • [ 32315-10-9 ]
  • [ 28721-09-7 ]
YieldReaction ConditionsOperation in experiment
85%
Stage #1: With triethylamine In toluene at 10 - 15℃; for 6 h;
Stage #2: With ammonia In water; toluene at 20℃; for 1 h;
) A solution of 66.9 g (0.3 mols) of 10-methoxy-iminostilbene and 34.92 g (0.34 mols) of triethylamine in 800 ml of toluene is gradually added, during 6 hours and at a temperature of 10-15°C, with a solution of 32.67 g (0.11 mols) of triphosgene in 300 ml of toluene. After completion of the reaction (disappearance of methoxy-iminostilbene) 200 ml of 30percent aqueous ammonia are added gradually, vigorously stirring at room temperature for some hours. After that, the phases are separated, the toluene phase is washed with water and evaporated to dryness under reduced pressure. Yield: 69.0 g (85percent on theoretical) of 10-methoxy-N-aminocarbonyl-iminostilbene (V) of purity higher than 95percent.
Reference: [1] Patent: EP1600443, 2005, A1, . Location in patent: Page/Page column 8
  • 2
  • [ 4698-11-7 ]
  • [ 232951-82-5 ]
  • [ 28721-09-7 ]
YieldReaction ConditionsOperation in experiment
80%
Stage #1: at 20℃; for 16 h; Inert atmosphere
Stage #2: With piperidine In dichloromethaneInert atmosphere
To a solution of 10-methoxy-5H-dibenz[b,f]azepine (3; 223.3 mg, 1.0 mmol) in CH2Cl2 (5 mL) at r.t. under argon was added FmocNCO (397.9 mg, 1.5 mmol). The mixture was stirred for 16 h, then piperidine (2.5 mL, 25.2 mmol) and MeOH (13 mL) were added successively. After the removal of MeOH, the residue was extracted with EtOAc. The organic layer was dried over MgSO4 and concentrated in vacuo, and the residue was purified by silica gel column chromatography (EtOAc–hexane, 1:2) to give 8 as a white solid; yield: 213 mg (0.800 mmol, 80percent); mp 193–194 °C. IR (ATR): 3476, 1666, 1600, 1402, 1133 cm–1. 1H NMR (600 MHz, CDCl3): δ = 7.73 (d, J = 7.3 Hz, 1 H), 7.45 (m, 3 H), 7.35 (m, 1 H), 7.27 (m, 3 H), 6.14 (s, 1 H), 5.20–4.10 (br, 2 H), 3.88 (s, 3H). 13C NMR (150 MHz, CDCl3): δ = 156.8, 156.0, 140.1, 138.5, 135.0, 134.6, 133.0, 130.4, 129.2, 128.2, 128.1, 127.7, 127.6, 127.5, 127.3, 55.4. HRMS (ESI): m/z [M + H]+ calcd for C16H14N2O2: 267.1128; found: 267.1123.
Reference: [1] Synthesis (Germany), 2015, vol. 47, # 24, p. 3907 - 3913
  • 3
  • [ 4698-11-7 ]
  • [ 28721-09-7 ]
YieldReaction ConditionsOperation in experiment
50%
Stage #1: With pyridinium p-toluenesulfonate In acetonitrile at 20℃; for 4 h;
Stage #2: With water In acetonitrile at 20℃; for 0.25 h;
[10-METHOXY-5H-DIBENZ (B, 0AZEPINE] (29.9 g, 0.134 mol) was added to 300 ml acetonitrile in a three-neck flask (500 ml) equipped with a mechanical stirring apparatus. The mixture was stirred at room temperature for 15 minutes, and then [NAOCN] (18 g, 0.277 mol) was added, followed by pyridiniump-toluenesulfonate (75 g, 0.3 mol). The mixture was stirred at room temperature for about 4 hours, at which time TLC indicated that the reaction was complete (disappearance of [10-METHOXY-5H-DIBENZ (BAZEPINE).] 30 ml water was added, and the mixture stirred for 15 minutes. The solids were filtered and the filtrate was concentrated under vacuum. The semi-solid residue was triturated with acetone to provide a creamy solid, which was dried at [80°] C to provide 18 g (0.068 mol, 50percent yield) of [10-METHOXY-5H-DIBENZ [B2FLAZEPINE-5-CARBOXAMIDE (10-METHOXYCARBAMAZEPINE).]
Reference: [1] Patent: WO2003/106414, 2003, A2, . Location in patent: Page 16-17
[2] Tetrahedron Letters, 2004, vol. 45, # 27, p. 5275 - 5278
[3] Patent: WO2003/106414, 2003, A2, . Location in patent: Page 14-15
[4] Patent: US2005/203297, 2005, A1, . Location in patent: Page/Page column 5; 6
[5] Patent: WO2009/139001, 2009, A2, . Location in patent: Page/Page column 9
[6] Patent: WO2007/141798, 2007, A1, . Location in patent: Page/Page column 14
[7] Patent: US2011/65917, 2011, A1, . Location in patent: Page/Page column 3-4
[8] Organic Process Research and Development, 2005, vol. 9, # 3, p. 272 - 277
  • 4
  • [ 28721-08-6 ]
  • [ 28721-09-7 ]
Reference: [1] Patent: WO2005/66133, 2005, A2, . Location in patent: Page/Page column 7
[2] Patent: WO2005/92862, 2005, A1, . Location in patent: Page/Page column 6
  • 5
  • [ 39507-06-7 ]
  • [ 28721-09-7 ]
Reference: [1] Tetrahedron Letters, 2004, vol. 45, # 27, p. 5275 - 5278
[2] Organic Process Research and Development, 2005, vol. 9, # 3, p. 272 - 277
  • 6
  • [ 353497-31-1 ]
  • [ 28721-09-7 ]
Reference: [1] Tetrahedron Letters, 2004, vol. 45, # 27, p. 5275 - 5278
[2] Organic Process Research and Development, 2005, vol. 9, # 3, p. 272 - 277
  • 7
  • [ 805236-74-2 ]
  • [ 28721-09-7 ]
Reference: [1] Tetrahedron Letters, 2004, vol. 45, # 27, p. 5275 - 5278
[2] Organic Process Research and Development, 2005, vol. 9, # 3, p. 272 - 277
  • 8
  • [ 353497-37-7 ]
  • [ 28721-09-7 ]
Reference: [1] Tetrahedron Letters, 2004, vol. 45, # 27, p. 5275 - 5278
[2] Organic Process Research and Development, 2005, vol. 9, # 3, p. 272 - 277
  • 9
  • [ 353497-35-5 ]
  • [ 28721-09-7 ]
Reference: [1] Tetrahedron Letters, 2004, vol. 45, # 27, p. 5275 - 5278
[2] Organic Process Research and Development, 2005, vol. 9, # 3, p. 272 - 277
  • 10
  • [ 3335-98-6 ]
  • [ 28721-09-7 ]
Reference: [1] Organic Process Research and Development, 2005, vol. 9, # 3, p. 272 - 277
[2] Organic Process Research and Development, 2005, vol. 9, # 3, p. 272 - 277
[3] Organic Process Research and Development, 2005, vol. 9, # 3, p. 272 - 277
  • 11
  • [ 731851-94-8 ]
  • [ 28721-09-7 ]
Reference: [1] Tetrahedron Letters, 2004, vol. 45, # 27, p. 5275 - 5278
  • 12
  • [ 590-28-3 ]
  • [ 4698-11-7 ]
  • [ 28721-09-7 ]
Reference: [1] Patent: US2005/203297, 2005, A1, . Location in patent: Page/Page column 5
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 28721-09-7 ]

Ethers

Chemical Structure| 89026-59-5

[ 89026-59-5 ]

4-(4-Methoxyphenyl)piperazine-1-carboxamide

Similarity: 0.73

Chemical Structure| 198479-63-9

[ 198479-63-9 ]

5-(Benzyloxy)-2-(4-(benzyloxy)phenyl)-3-methyl-1H-indole

Similarity: 0.72

Chemical Structure| 618910-07-9

[ 618910-07-9 ]

8-Methoxy-5-methyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole

Similarity: 0.71

Chemical Structure| 160893-04-9

[ 160893-04-9 ]

5-Methoxyquinolin-2(1H)-one

Similarity: 0.70

Chemical Structure| 3526-43-0

[ 3526-43-0 ]

N-(4-Methoxybenzyl)aniline

Similarity: 0.70

Amides

Chemical Structure| 36507-30-9

[ 36507-30-9 ]

1aH-Dibenzo[b,f]oxireno[2,3-d]azepine-6(10bH)-carboxamide

Similarity: 0.79

Chemical Structure| 29331-92-8

[ 29331-92-8 ]

10-Hydroxy-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide

Similarity: 0.75

Chemical Structure| 89026-59-5

[ 89026-59-5 ]

4-(4-Methoxyphenyl)piperazine-1-carboxamide

Similarity: 0.73

Chemical Structure| 160893-04-9

[ 160893-04-9 ]

5-Methoxyquinolin-2(1H)-one

Similarity: 0.70

Chemical Structure| 3564-73-6

[ 3564-73-6 ]

10,11-Dihydro-5H-dibenzo[b,f]azepine-5-carboxamide

Similarity: 0.70

Ureas

Chemical Structure| 36507-30-9

[ 36507-30-9 ]

1aH-Dibenzo[b,f]oxireno[2,3-d]azepine-6(10bH)-carboxamide

Similarity: 0.79

Chemical Structure| 29331-92-8

[ 29331-92-8 ]

10-Hydroxy-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide

Similarity: 0.75

Chemical Structure| 89026-59-5

[ 89026-59-5 ]

4-(4-Methoxyphenyl)piperazine-1-carboxamide

Similarity: 0.73

Chemical Structure| 3564-73-6

[ 3564-73-6 ]

10,11-Dihydro-5H-dibenzo[b,f]azepine-5-carboxamide

Similarity: 0.70

Chemical Structure| 54582-35-3

[ 54582-35-3 ]

1-(4-Methoxybenzyl)urea

Similarity: 0.69

Amines

Chemical Structure| 36507-30-9

[ 36507-30-9 ]

1aH-Dibenzo[b,f]oxireno[2,3-d]azepine-6(10bH)-carboxamide

Similarity: 0.79

Chemical Structure| 29331-92-8

[ 29331-92-8 ]

10-Hydroxy-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide

Similarity: 0.75

Chemical Structure| 89026-59-5

[ 89026-59-5 ]

4-(4-Methoxyphenyl)piperazine-1-carboxamide

Similarity: 0.73

Chemical Structure| 3526-43-0

[ 3526-43-0 ]

N-(4-Methoxybenzyl)aniline

Similarity: 0.70

Chemical Structure| 3564-73-6

[ 3564-73-6 ]

10,11-Dihydro-5H-dibenzo[b,f]azepine-5-carboxamide

Similarity: 0.70

Related Parent Nucleus of
[ 28721-09-7 ]

Other Aromatic Heterocycles

Chemical Structure| 36507-30-9

[ 36507-30-9 ]

1aH-Dibenzo[b,f]oxireno[2,3-d]azepine-6(10bH)-carboxamide

Similarity: 0.79

Chemical Structure| 29331-92-8

[ 29331-92-8 ]

10-Hydroxy-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide

Similarity: 0.75

Chemical Structure| 618910-07-9

[ 618910-07-9 ]

8-Methoxy-5-methyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole

Similarity: 0.71

Chemical Structure| 3564-73-6

[ 3564-73-6 ]

10,11-Dihydro-5H-dibenzo[b,f]azepine-5-carboxamide

Similarity: 0.70

Chemical Structure| 62208-68-8

[ 62208-68-8 ]

Benzofuro[3,2-d]pyrimidine-2,4(1H,3H)-dione

Similarity: 0.66